FAKTOR-OPTIONSSCHEIN - RESMED | Market Closed - Bid/Ask 11:28:53 05/06/2024 pm IST | After market 11:56:11 pm | |||
| 2.24 EUR | +6.16% |
|
2.245 | +0.22% |
| Current month | +18.54% | ||
| 1 month | -37.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 2.24 | +6.16% |
| 04/24/04 | 2.11 | +17.22% |
| 03/24/03 | 1.8 | +1.12% |
| 31/24/31 | 1.78 | -9.64% |
| 30/24/30 | 1.97 | +10.06% |
Delayed Quote Börse Stuttgart
Last update June 05, 2024 at 11:28 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | ME010X |
| ISIN | DE000ME010X2 |
| Date issued | 23/08/2023 |
| Strike | 187.8 $ |
| Maturity | Unlimited |
| Parity | 10.27 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.93 € |
|---|---|
| Lowest since issue | 0.66 € |
| Spread | 0.05 € |
| Spread % | 2.16% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.2
USD
Average target price
216.6
USD
Spread / Average Target
+2.59%
- Stock Market
- Certificates
- Certificat
